1. Home
  2. KTOS vs BBIO Comparison

KTOS vs BBIO Comparison

Compare KTOS & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kratos Defense & Security Solutions Inc.

KTOS

Kratos Defense & Security Solutions Inc.

HOLD

Current Price

$75.77

Market Cap

14.5B

Sector

Industrials

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$72.59

Market Cap

15.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTOS
BBIO
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5B
15.3B
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
KTOS
BBIO
Price
$75.77
$72.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
25
Target Price
$97.44
$83.96
AVG Volume (30 Days)
4.0M
2.0M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
N/A
EPS
0.13
N/A
Revenue
$751,900,000.00
$502,076,000.00
Revenue This Year
$25.63
$88.16
Revenue Next Year
$23.29
$74.13
P/E Ratio
$615.38
N/A
Revenue Growth
12.44
126.26
52 Week Low
$27.51
$28.33
52 Week High
$134.00
$84.94

Technical Indicators

Market Signals
Indicator
KTOS
BBIO
Relative Strength Index (RSI) 36.35 55.68
Support Level $70.49 $70.65
Resistance Level $81.53 $78.83
Average True Range (ATR) 5.12 2.88
MACD -1.17 0.52
Stochastic Oscillator 2.85 70.89

Price Performance

Historical Comparison
KTOS
BBIO

About KTOS Kratos Defense & Security Solutions Inc.

Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: